Discovery of a tetrahydroisoquinoline-based CDK9-cyclin T1 protein-protein interaction inhibitor as an anti-proliferative and anti-migration agent against triple-negative breast cancer cells
Keyword(s):
Keyword(s):
2021 ◽
Vol 34
◽
pp. 102383
Keyword(s):
2016 ◽
Vol 48
(3)
◽
pp. 1016-1028
◽